You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》醫脈通(02192.HK)招股價上限27.2元定價 一手中籤率5%
阿思達克 07-14 09:11
將於明日掛牌上市的中國在線醫師平台醫脈通(02192.HK)公布發售價及配發結果,於全球發行1.55億股,原計劃其中1,551萬股於本港公開發售,該股公開發售超購591.41倍,經重新分配後,相關部份佔整體發售佔比提升至50%。認購一手中籤率5%,認購90手才可穩獲一手。

每股發售價定於27.2元,為招股價區間24.1元至27.2元的上限。集資淨額料為40.01億元,若超額配股權獲悉數行使將額外增加6.33億元。

根據公司早前簽訂基石投資者協議,以每股發售價27.2元計,FMR、富達國際、騰訊(00700.HK)全資附屬Tencent Mobility及GIC各持有公司1,141.55萬股,持股1.65%。另外Matthews Funds、Springhill及OrbiMed Funds各持有公司570.75萬股,持股0.83%。

聯席保薦人為高盛及海通國際,聯席全球協調人、聯席賬簿管理人及聯席牽頭經辦人為高盛、海通國際及中金公司。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account